Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb 20:5:70.
doi: 10.3389/fphys.2014.00070. eCollection 2014.

Pancreatic cancer risk in hereditary pancreatitis

Frank U Weiss  1
Affiliations
Review

Pancreatic cancer risk in hereditary pancreatitis

Frank U Weiss. Front Physiol. .

Abstract

Inflammation is part of the body's immune response in order to remove harmful stimuli-like pathogens, irritants or damaged cells-and start the healing process. Recurrent or chronic inflammation on the other side seems a predisposing factor for carcinogenesis and has been found associated with cancer development. In chronic pancreatitis mutations of the cationic trypsinogen (PRSS1) gene have been identified as risk factors of the disease. Hereditary pancreatitis (HP) is a rare cause of chronic pancreatic inflammation with an early onset, mostly during childhood. HP often starts with recurrent episodes of acute pancreatitis and the clinical phenotype is not very much different from other etiologies of the disease. The long-lasting inflammation however generates a tumor promoting environment and represents a major risk factor for tumor development This review will reflect our knowledge concerning the specific risk of HP patients to develop pancreatic cancer.

Keywords: PRSS1; cancer risk; chronic inflammation; hereditary pancreatitis; pancreatitis.

PubMed Disclaimer

References

    1. Avila J. L., Kissil J. L. (2013). Notch signaling in pancreatic cancer: oncogene or tumor suppressor? Trends Mol. Med. 19, 320–327 10.1016/j.molmed.2013.03.003 - DOI - PMC - PubMed
    1. Balkwill F., Mantovani A. (2001). Inflammation and cancer: back to Virchow? Lancet 357, 539–545 10.1016/S0140-6736(00)04046-0 - DOI - PubMed
    1. Brand R. E., Lerch M. M., Rubinstein W. S., Neoptolemos J. P., Whitcomb D. C., Hruban R. H., et al. (2007). Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 56, 1460–1469 10.1136/gut.2006.108456 - DOI - PMC - PubMed
    1. Comfort M. W., Steinberg A. G. (1952). Pedigree of a family with hereditary chronic relapsing pancreatitis. Gastroenterology 21, 54–63 - PubMed
    1. Condeelis J., Pollard J. W. (2006). Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263–266 10.1016/j.cell.2006.01.007 - DOI - PubMed